A 9-month-old infant have remittent fever for the last 4 days with nasal congestion and mild cough, today he developed maculopapular rash after subsidence of the fever. Of the following, the MOST likely diagnosis is

Questions 91

ATI RN

ATI RN Test Bank

Infectious Disease Pediatric Questions

Question 1 of 5

A 9-month-old infant have remittent fever for the last 4 days with nasal congestion and mild cough, today he developed maculopapular rash after subsidence of the fever. Of the following, the MOST likely diagnosis is

Correct Answer: B

Rationale: Roseola (B) typically presents with high fever for days, followed by a rash after fever subsides, common in infants, unlike rubella (A), measles (C), scarlet fever (D), or Kawasaki (E).

Question 2 of 5

Of the following, the MOST common viral cause of common cold is

Correct Answer: B

Rationale: Rhinoviruses (B) cause ~50% of common colds, per virology data, outranking others (A, C, D, E).

Question 3 of 5

A 7-year-old child presented with persistent mucopurulent rhinorrhea, nasal stuffiness, headache and cough, mainly at night preceded by history flue like illness; on examination there are facial swelling and tenderness. Of the following, the major predisposing factor for the development of this condition is

Correct Answer: D

Rationale: Sinusitis here follows a flu-like illness (common cold, D), the primary predisposing factor via obstruction and infection, per pediatric sinusitis data.

Question 4 of 5

A 2-year-old child presented with recurrent attacks of stridor and harsh cough, sudden in onset mainly at night with no fever; most of the time the stridor relieved during the trip to hospital. Of the following, the MOST likely diagnosis is

Correct Answer: C

Rationale: Spasmodic croup (C) features recurrent, sudden nocturnal stridor and cough without fever, often resolving spontaneously, per pediatric ENT.

Question 5 of 5

Monthly injections of palivizumab, a RSV-specific monoclonal antibody, initiated just before the onset of the RSV season confers some protection from severe RSV disease. Palivizumab is indicated for some infants under 2 years old with all the following EXCEPT

Correct Answer: A

Rationale: Palivizumab is for high-risk infants (B, C, D, E). Asthma (A) alone isn’t an indication, per AAP guidelines.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions